Opportunity Information: Apply for PA 07 227

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Neuroscience Research on Drug Abuse (R21)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
  • This funding opportunity was created on Dec 5, 2008 and posted on Feb 21, 2007.
  • Applicants must submit their applications by Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $200,000.00 in funding.
  • Eligible applicants include: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Special district governments Others (see text field entitled Additional Information on Eligibility for clarification) City or township governments Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) County governments Small businesses Independent school districts State governments.
  • Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith based or community based organizations can apply.
Apply for PA 07 227

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, is soliciting applications for exploratory neuroscience and behavioral neuroscience studies that can improve understanding of how drug abuse and addiction develop and persist. The focus is on the biological and behavioral processes and mechanisms involved across the full course of substance use and substance use disorders, including initial use, escalation, dependence, addiction, withdrawal, and treatment or recovery-related processes. Projects may use a wide range of approaches and study systems, including computational or other model systems, animal studies, and research with human participants, as long as the work is clearly tied to mechanisms relevant to drug abuse and addiction.

This opportunity uses the NIH R21 Research Project Grant mechanism, which is typically intended for early-stage, exploratory, or high-risk/high-reward work where the goal is to generate foundational data, test a novel idea, or open up a new line of investigation rather than complete a large, multi-year research program. The announcement is one of several parallel options with the same scientific scope: investigators with projects that fit better as a larger or more mature effort are directed to the companion R01 announcement (PA 07 226), while smaller, more limited projects may be suitable for the R03 (PA 07 228). Similar scientific ideas may also be submitted under the Academic Research Enhancement Award (R15), which is aimed at strengthening research at eligible institutions.

Budget and project period are not fixed because NIDA expects applications to vary widely in complexity, methods, and scope. The award ceiling listed is $200,000, and the total number of awards and overall dollars committed will depend on the number of applications received, their scientific quality, and their requested durations and costs. There is no cost sharing or matching requirement, which means applicants are not required to contribute non-federal funds as a condition of receiving an award.

Eligibility is broad and includes many types of organizations and governments. Eligible applicants include public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), for-profit organizations (other than small businesses as well as small businesses), and a range of governmental entities such as state governments, counties, cities or townships, special district governments, and independent school districts. Tribal governments and tribal organizations are also eligible, as are public housing authorities/Indian housing authorities. Importantly, foreign institutions may apply, eligible federal agencies may apply, and faith-based or community-based organizations are explicitly included as eligible applicants.

The opportunity is identified as Funding Opportunity Number PA 07 227, categorized as a discretionary grant within health and education-related activity areas, and associated with CFDA 93.279 (Drug Abuse and Addiction Research Programs). It was posted February 21, 2007, with multiple receipt dates (meaning applications are accepted on recurring standard NIH due dates rather than a single deadline). The archived date is June 1, 2010, and applicants are directed to the full NIH guide announcement for the complete requirements, submission instructions, and receipt date details at http://grants.nih.gov/grants/guide/pa-files/PA-07-227.html. For technical issues accessing the announcement, the NIH Office of Extramural Research webmaster is listed as the contact point.

Frequently Asked Questions (FAQs) - NIDA/NIH R21 Exploratory Neuroscience and Behavioral Neuroscience Studies (PA-07-227)

1) What is this funding opportunity?

This is a National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH) funding opportunity seeking applications for exploratory neuroscience and behavioral neuroscience studies that improve understanding of how drug abuse and addiction develop and persist. The Funding Opportunity Number is PA-07-227.

2) What is the overall scientific focus of PA-07-227?

The focus is on biological and behavioral processes and mechanisms across the full course of substance use and substance use disorders, including initial use, escalation, dependence, addiction, withdrawal, and treatment- or recovery-related processes.

3) What types of research approaches are allowed under this announcement?

A wide range of approaches and study systems may be used, including computational or other model systems, animal studies, and research with human participants, as long as the work is clearly tied to mechanisms relevant to drug abuse and addiction.

4) Does the project have to cover the entire course of substance use disorder (from initiation through recovery)?

No specific requirement is stated that a single project must cover every stage. The announcement highlights that NIDA is interested in mechanisms across the full course (initial use through recovery-related processes), so projects can target stages that are relevant to the proposed mechanistic question.

5) What grant mechanism is used for this opportunity?

This opportunity uses the NIH R21 Research Project Grant mechanism.

6) What is an R21 intended for in this context?

The R21 is described as typically intended for early-stage, exploratory, or high-risk/high-reward work where the goal is to generate foundational data, test a novel idea, or open a new line of investigation rather than complete a large, multi-year research program.

7) If my project is larger or more mature than an R21, is there another option?

Yes. Investigators with projects that fit better as a larger or more mature effort are directed to a companion R01 announcement: PA 07 226.

8) If my project is smaller or more limited than an R21, is there another option?

Yes. Smaller, more limited projects may be suitable for the R03 announcement: PA 07 228.

9) Are there other NIH mechanisms mentioned for similar scientific ideas?

Yes. Similar scientific ideas may also be submitted under the Academic Research Enhancement Award (R15), which is aimed at strengthening research at eligible institutions.

10) What is the maximum award amount mentioned for PA-07-227?

The listed award ceiling is $200,000.

11) Are the budget and project period fixed for this opportunity?

No. Budget and project period are not fixed because NIDA expects applications to vary widely in complexity, methods, and scope.

12) How many awards will be made, and how much total funding is available?

The total number of awards and overall dollars committed will depend on the number of applications received, their scientific quality, and their requested durations and costs.

13) Is cost sharing or matching required?

No. There is no cost sharing or matching requirement, meaning applicants are not required to contribute non-federal funds as a condition of receiving an award.

14) Who is eligible to apply?

Eligibility is broad and includes many types of organizations and governments. Eligible applicants include public and private institutions of higher education; nonprofit organizations (including those with and without 501(c)(3) status); for-profit organizations (including small businesses and other than small businesses); and governmental entities such as state governments, counties, cities or townships, special district governments, and independent school districts.

15) Are tribal governments and tribal organizations eligible?

Yes. Tribal governments and tribal organizations are explicitly listed as eligible.

16) Are public housing authorities eligible?

Yes. Public housing authorities/Indian housing authorities are included as eligible applicants.

17) Can foreign institutions apply?

Yes. Foreign institutions may apply.

18) Can federal agencies apply?

Yes. Eligible federal agencies may apply.

19) Are faith-based or community-based organizations eligible?

Yes. Faith-based and community-based organizations are explicitly included as eligible applicants.

20) What is the CFDA number associated with this opportunity?

This opportunity is associated with CFDA 93.279 (Drug Abuse and Addiction Research Programs).

21) What type of grant is PA-07-227 categorized as?

It is categorized as a discretionary grant within health and education-related activity areas.

22) When was this opportunity posted?

It was posted on February 21, 2007.

23) Is there a single deadline, or are there multiple receipt dates?

There are multiple receipt dates, meaning applications are accepted on recurring standard NIH due dates rather than a single deadline.

24) What does it mean that this opportunity is archived?

The archived date is listed as June 1, 2010.

25) Where can applicants find the full announcement and official instructions?

Applicants are directed to the full NIH guide announcement for complete requirements, submission instructions, and receipt date details at: http://grants.nih.gov/grants/guide/pa-files/PA-07-227.html

26) Who should be contacted for technical issues accessing the announcement?

For technical issues accessing the announcement, the NIH Office of Extramural Research webmaster is listed as the contact point.

Browse more business programs for Drug Abuse Research and Prevention

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Neuroscience Research on Drug Abuse(R03)

Previous opportunity: Neuroscience Research on Drug Abuse (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 07 227

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 07 227) also looked into and applied for these:

Funding Opportunity
Neuroscience Research on Drug Abuse(R03) Apply for PA 07 228

Funding Number: PA 07 228
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $50,000
Collaborative Clinical Trials in Drug Abuse (R01) Apply for PAR 07 232

Funding Number: PAR 07 232
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01) Apply for PA 07 329

Funding Number: PA 07 329
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21) Apply for PA 07 331

Funding Number: PA 07 331
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03) Apply for PA 07 330

Funding Number: PA 07 330
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Medications Development for the Treatment of Amphetamine and Amphetamine Like Related Disorders (R01) Apply for PA 07 333

Funding Number: PA 07 333
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Medications Development for the Treatment of Amphetamine and Amphetamine Like Related Disorders (R21) Apply for PA 07 334

Funding Number: PA 07 334
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Development of Animal Models and Related Biological Materials For Research (R21) Apply for PA 07 336

Funding Number: PA 07 336
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
HIV Treatment Adherence Research (R01) Apply for PA 07 338

Funding Number: PA 07 338
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
HIV Treatment Adherence Research (R03) Apply for PA 07 339

Funding Number: PA 07 339
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
HIV Treatment Adherence Research (R21) Apply for PA 07 340

Funding Number: PA 07 340
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Developing And Improving Institutional Animal Resources (G20) Apply for PAR 07 342

Funding Number: PAR 07 342
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
AIDS Science Track Award for Research Transition (R03) Apply for PA 07 349

Funding Number: PA 07 349
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Bioengineering and Obesity (R01) Apply for PA 07 354

Funding Number: PA 07 354
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Improving Heart Failure Disease Management (R01) Apply for PA 07 355

Funding Number: PA 07 355
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Clinical Cancer Therapy and Prevention Research (R01) Apply for PA 07 356

Funding Number: PA 07 356
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Exploratory Cancer Prevention Studies Involving Molecular Targets for Bioactive Food Components (R21) Apply for PA 07 362

Funding Number: PA 07 362
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Medications Development for the Treatment of Cannabis Related Disorders (R01) Apply for PA 07 365

Funding Number: PA 07 365
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Medications Development for the Treatment of Cannabis Related Disorders (R21) Apply for PA 07 366

Funding Number: PA 07 366
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Omics and Variable Responses to CAM Secondary Analysis of CAM Clinical Trials (R01) Apply for PAR 07 377

Funding Number: PAR 07 377
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 227", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.